Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jean Marie Ruddy

Vascular Surgery Charleston, SC Medical Doctor

NPI 1770665796 CMS profile 352606

171 Ashley Ave, Charleston, SC 29425

Open in the dashboard

General payments

$54,011

108 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$155,570 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Jean Marie Ruddy of Charleston, SC is reported in the CMS Open Payments database as having received $54,011 across 108 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $155,570 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,170 12
2024 General $3,550 5
2023 General $396 4
2022 General $8,814 20
2021 General $21,247 44
2020 General $14,567 20
2019 General $267 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jean Marie Ruddy
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Jean Marie Ruddy were reported at $5,170. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Jean Marie Ruddy Vascular Surgery median Middle half National median
2019 $267 $796 $226–$2,363 $163
2020 $14,567 $348 $118–$1,110 $114
2021 $21,247 $471 $158–$1,421 $132
2022 $8,814 $725 $222–$2,183 $149
2023 $396 $836 $257–$2,440 $160
2024 $3,550 $909 $252–$2,619 $164
2025 $5,170 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CVRx, Inc. $51,345 79 payments
  2. W. L. Gore & Associates, Inc. $1,251 14 payments
  3. Cook Medical LLC $448 5 payments
  4. Innovation Technologies Inc $156 1 payment
  5. Medtronic, Inc. $150 1 payment
  6. Medtronic Vascular, Inc. $144 1 payment
  7. KCI USA, Inc $112 1 payment
  8. Dilon Technologies, Inc. $100 1 payment
  9. Abbott Laboratories $97 1 payment
  10. Boston Scientific Corporation $76 1 payment
  11. Other $131 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $39,600 14 payments
  2. Travel and Lodging $9,841 42 payments
  3. Food and Beverage $4,569 52 payments
Products named General payments · program years 2019–2025
  1. Barostim Neo System $51,345 79 payments
  2. GORE VIABAHN VBX Balloon Expandable Endo $883 9 payments
  3. VIABAHN VBX Balloon Expandable Endoprosthesis $320 4 payments
  4. Zenith Spiral-Z $199 3 payments
  5. Irrisept $156 1 payment
  6. ENDURANT IIS $150 1 payment
  7. Endurant $144 1 payment
  8. ZENITH ALPHA $125 1 payment
  9. Zilver PTX $124 1 payment
  10. PREVENA $112 1 payment
  11. Other $588 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$67,209

Medicare's payments for the services billed

Medicare patients

945

Average age 73

Services billed

1,208

481 women, 464 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 44%
Diabetes 36%
Chronic kidney disease 34%
Heart failure 32%
Atrial fibrillation 28%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record